Compare UONEK & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UONEK | BEAT |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | 1272 | 17 |
| Industry | Broadcasting | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 31.6M |
| IPO Year | N/A | N/A |
| Metric | UONEK | BEAT |
|---|---|---|
| Price | $4.90 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 20.1K | ★ 660.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.51 |
| 52 Week High | $9.38 | $4.00 |
| Indicator | UONEK | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 33.62 |
| Support Level | $4.51 | N/A |
| Resistance Level | $5.19 | $0.79 |
| Average True Range (ATR) | 0.49 | 0.06 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 95.27 | 4.14 |
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.